(NASDAQ:MEOH), NEW YORK, March 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Methanex Corporation (“Methanex” or the “Company”) (NASDAQ: MEOH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Methanex and certain of its officers and/or directors have engaged […]

(NASDAQ:DAKT), NEW YORK, March 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Daktronics, Inc. (“Daktronics” or the “Company”) (NASDAQ: DAKT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Daktronics and certain of its officers and/or directors have engaged

(NASDAQ:IRBT), NEW YORK, March 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of iRobot Corporation (“iRobot” or the “Company”) (NASDAQ: IRBT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether iRobot and certain of its officers and/or directors have engaged

(NASDAQ:OSIS), NEW YORK, March 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of OSI Systems, Inc. (“OSI” or the “Company”) (NASDAQ: OSIS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether OSI and certain of its officers and/or directors have

(NYSE:XPOF), NEW YORK, March 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Xponential Fitness, Inc. (“Xponential” or the “Company”) (NYSE: XPOF). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Xponential and certain of its officers and/or directors have

(NASDAQ:PROF), NEW YORK, March 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Profound Medical Corp. (“Profound” or the “Company”) (NASDAQ: PROF). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Profound and certain of its officers and/or directors have

(NYSE:RLX), NEW YORK, March 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of RLX Technology Inc. (“RLX” or the “Company”) (NYSE: RLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether RLX and certain of its officers and/or directors have

(NasdaqGM:BITF), NEW YORK, March 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Bitfarms Ltd. (“Bitfarms” or the “Company”) (NASDAQ: BITF). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Bitfarms and certain of its officers and/or directors have engaged

(NASDAQ:AFRM), NEW YORK, March 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Affirm Holdings, Inc. (“Affirm” or the “Company”) (NASDAQ: AFRM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Affirm and certain of its officers and/or directors have

(NYSE:SEI), NEW YORK, March 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Solaris Energy Infrastructure, Inc. (“SEI” or the “Company”) (NYSE: SEI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether SEI and certain of its officers and/or directors